Work

PDE1B KO Confers Resilience to Acute Stress-induced Depression-like Behavior

Year: 2017
Type: article
Abstract: Phosphodiesterases (PDE) regulate secondary messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by hydrolyzing the phosphodiester bond.There are over 100 PDE proteins that are categorized into 11 families.Each protein family has a unique tissue distribution and binding affinity for cAMP and/or cGMP.The modulation of different PDEs has been used to treat several disorders: inflammation, erectile dysfunction, and neurological disorders.Recently, PDE inhibitors were implicated for therapeutic benefits in Alzheimer's disease, depression, Huntington's disease, Parkinson's disease, schizophrenia, and substance abuse.PDE1B is found in the caudate-putamen, nucleus accumbens, dentate gyrus, and substantia nigra-areas linked to depression.PDE1B expression is also increased after acute and chronic stress.Two ubiquitous Pde1b knockout (KO) mouse models, both removing part of the catalytic region, decreased immobility on two acute stress tests associated with depression-like behavior; tail suspension test (TST) and forced swim test (FST).The decreases in immobility suggest resistance to depression-like behavior, and these effects were additive when combined with two current antidepressants, fluoxetine and bupropion.The resistance to induced immobility was seen when PDE1B was knocked down during adolescence or earlier.Expression of Pde1b mRNA and protein showed that Pde1b is localized to dopaminergic and glutamatergic post-synaptic cells.Serotonin transporter, dopamine transporter, and dopamine receptor D 1a (Drd1a) Cre drivers were tested and only Pde1b KO in Drd1a specific cells was sufficient to reproduce the immobility phenotype in TST.Intrastriatal injections of dopamine receptor, D 1 , agonist (SKF38393) and antagonist (SCH23390) revealed an additive immobility effect of Pde1b KO and dopamine receptor antagonism.The D 1 agonist reversed the genotype immobility phenotype.The results suggest that reduction of PDE1B causes resistance to acute stress-induced depression-like behaviors through the dopamine pathways.iii iv ACKNOWLEDGEMENTS I would like to thank my advisor, Dr. Charles Vorhees, for providing the opportunity to learn and perform research in his laboratory, his encouragement and guidance, and for his dedication to leading his students through the roller coaster that is graduate school.I would also like to thank Dr. Michael Williams and Dr. Matthew Skelton for their constant technical support throughout this entire process.In addition I would like to thank the Vorhees, Williams, and Skelton laboratory members both past and present, especially Chiho Sugimoto for her willingness to always help.The entirety of my committee also deserves significant acknowledgements for their advice and guidance of the following
Language: English
Open Access status: green
OpenAlex ID: W7023666495
FWCI:
Cites: 175
Cited by:
Related to: 10